ACR & SBI: Norwegian mammo overdiagnosis analysis flawed

The American College of Radiology (ACR) and the Society of Breast Imaging (SBI) have responded to a study in the Annals of Internal Medicine which concluded that 15 to 25 percent of cancers in the Norwegian mammography screening program are overdiagnosed, saying those overdiagnosis rates are overestimated, according to a statement on ACR’s website.

The ACR/SBI statement said the analysis from Kalager et al, published April 3 in Annals, is “flawed” and comes to invalid conclusions about the value of mammography screening.

“The truth is that the Norwegian screening program is too early in its inception, and there is too little follow-up, to draw conclusions about the effectiveness and side effects of mammography with any measurable confidence,” read the statement.

Other studies with long-term follow-ups of national programs introduced before Norway’s offer better estimates of mammography screening performance, according to ACR and SBI. The statement cites the Two-County Trial in Sweden and the U.K. mammography screening program as two programs offering more robust data supporting the benefits of mammography screening. The former estimated that there are 7.5 to 10 deaths prevented for every 2,500 women invited to be screened every two to 2.5 years over 10 years, and the latter showed that two to 2.5 lives are saved for every case of overdiagnosis.

“The more robust, more mature, and more carefully analyzed data not only prove the life-saving benefits of mammography screening, but also indicate a much smaller frequency of harms (including overdiagnosis) than what is suggested by Kalager et al,” said ACR and SBI.

Michael N. Linver, MD, director of mammography at X-Ray Associates of New Mexico, echoed the ACR/SBI statement’s focus on long-term follow-up studies in a previously published interview with Health Imaging.
 

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.